ImageneBio, Inc. (IMA)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$4.13

-0.02 (-0.49%)

Market Cap: $47.21M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

81%(17/21)

Avg Surprise

-32.17%

Streak

1 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.85

Range$-0.98 - $-0.72

3 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$-1.24+31.4%

60d ago$-1.24+31.4%

30d ago$-1.24+31.4%

7d ago$-0.78-8.6%

Current$-0.85

Revenue Consensus

Range$0 - $0

4 analysts

Period ending Dec 31, 2026

EPS Consensus$-0.83

Range$-1.09 - $-0.70

3 analysts

Revenue Consensus

Range$0 - $0

4 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-0.83	$-1.09 - $-0.70	-	-	3	-	-
Sep 30, 2026Sep 26EST	-	$-0.85	$-0.98 - $-0.72	-	-	3	2 0 30d	-
Jun 30, 2026Jun 26 Reported Jul 23, 2026Reported Jul 23	$-0.63	$-0.90	$-1.23 - $-0.72	+30.00%	Beat	3	1 1 30d	+8.7%
Mar 31, 2026Mar 26 Reported May 7, 2026Reported May 7	$-0.95	$-0.66	$-0.66 - $-0.66	-43.94%	Miss	1	No revisions (30d)	-458.8%
Dec 31, 2025Dec 25 Reported Mar 10, 2026Reported Mar 10	$-0.62	$-1.15	$-1.15 - $-1.15	+46.28%	Beat	1	No revisions (30d)	-208.9%
Sep 30, 2025Sep 25 Reported Nov 12, 2025Reported Nov 12	$-2.91	$-1.00	$-1.00 - $-1.00	-191.00%	Miss	1	No revisions (30d)	-1285.7%
Jun 30, 2025Jun 25 Reported Jul 24, 2025Reported Jul 24	$-0.69	$-0.14	-	-386.94%	Miss	-	-	-146.4%
Mar 31, 2025Mar 25 Reported May 8, 2025Reported May 8	$-0.17	$-0.19	-	+11.41%	Beat	-	-	+48.5%
Dec 31, 2024Dec 24 Reported Mar 6, 2025Reported Mar 6	$-0.20	$-0.21	-	+3.24%	Beat	-	-	+51.2%
Sep 30, 2024Sep 24 Reported Nov 7, 2024Reported Nov 7	$-0.21	$-0.25	-	+17.61%	Beat	-	-	+47.5%
Jun 30, 2024Jun 24 Reported Aug 8, 2024Reported Aug 8	$-0.28	$-0.36	-	+22.22%	Beat	-	-	+36.4%
Mar 31, 2024Mar 24 Reported May 13, 2024Reported May 13	$-0.33	$-0.33	-	+0.00%	Beat	-	-	+15.4%
Dec 31, 2023Dec 23 Reported Mar 12, 2024Reported Mar 12	$-0.41	$-0.41	-	+0.00%	Beat	-	-	-5.1%
Sep 30, 2023Sep 23 Reported Nov 9, 2023Reported Nov 9	$-0.40	$-0.40	-	+0.00%	Beat	-	-	+16.7%
Jun 30, 2023Jun 23 Reported Aug 10, 2023Reported Aug 10	$-0.44	$-0.44	-	+0.00%	Beat	-	-	+22.8%
Mar 31, 2023Mar 23 Reported May 15, 2023Reported May 15	$-0.39	$-0.39	-	+0.00%	Beat	-	-	+17.0%
Dec 31, 2022Dec 22 Reported Mar 14, 2023Reported Mar 14	$-0.39	$-0.39	-	+0.00%	Beat	-	-	-657.1%
Sep 30, 2022Sep 22 Reported Nov 7, 2022Reported Nov 7	$-0.48	$-0.48	-	+0.00%	Beat	-	-	-20.0%
Jun 30, 2022Jun 22 Reported Aug 11, 2022Reported Aug 11	$-0.57	$-0.57	-	+0.00%	Beat	-	-	+69.8%
Mar 31, 2022Mar 22 Reported May 12, 2022Reported May 12	$-0.47	$-0.47	-	+0.00%	Beat	-	-	+81.3%
Dec 31, 2021Dec 21 Reported Mar 17, 2022Reported Mar 17	$0.07	$0.07	-	+0.00%	Beat	-	-	+146.7%
Sep 30, 2021Sep 21 Reported Nov 10, 2021Reported Nov 10	$-0.40	$-0.42	-	+4.76%	Beat	-	-	-
Jun 30, 2021Jun 21 Reported Aug 12, 2021Reported Aug 12	$-1.89	N/A	-	N/A	Beat	-	-	-
Mar 31, 2021Mar 21 Reported May 13, 2021Reported May 13	$-2.52	$-0.87	-	-189.22%	Miss	-	-	-
Dec 31, 2020Dec 20 Reported Mar 26, 2021Reported Mar 26	$-0.15	$0.00	-	N/A	Miss	-	-	-

Key Metrics

Valuation
P/E Ratio	-0.81	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-82.70%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	N/A
Current Ratio	21.47x	Quick Ratio	21.47x
Trading Statistics
Beta	N/A	Avg Volume	16.24K
52-Week High	$9.10	52-Week Low	$3.90

Technical Indicators Dashboard

Moving Averages

SMA 10$4.38

SMA 20$4.55

SMA 50$5.03

SMA 200$5.78

EMA 10$4.34

EMA 20$4.52

EMA 50$4.90

EMA 200$6.17

MACD

Line: -0.24Signal: -0.21Hist: -0.02

ADX

ADX: 33.3+DI: 7.7-DI: 35.1

Aroon & PSAR

Aroon Up8.0

Aroon Down100.0

PSAR$4.67

Bollinger Bands

Upper Band$5.04

Lower Band$4.06

%B Position2157%(Upper)

Band Width0.08

RSI (14-Day)

Oversold

23.1

Momentum Oscillators

Stoch %K21.1

Stoch %D23.6

Williams %R-82.9

ROC (10d)-9.8%

Momentum-0.45

CCI (20d)-130.7

MFI (14d)27.4

Volatility Measures

ATR (14d)$0.22(5.4%)

StdDev (20d)0.25

Hist Vol33.4%(Moderate)

Volume Flow

VWAP$4.12

OBV16.2M

AD Line4.9B

CMF (20d)-0.225

Volume Metrics

Avg Vol (20d)15.7K

Vol Ratio1.4x

VWMA (20d)$4.56

Pivot Points

R3$4.25

R2$4.22

R1$4.19

Pivot Point$4.16

S1$4.13

S2$4.10

S3$4.07

Advanced Oscillators

TSI-43.85

Ultimate Osc50.8

KST-138.56

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$0	$0	$800,000	$0	$0	$800,000	$0	$3.50M	$0	$0	$658,000	$1.19M
Cost of Revenue	$0	$0	$561,000	$0	$0	$0	$4.58M	$0	$0	$0	$305,000	$0
Gross Profit	$0	$0	$800,000	$0	$0	$800,000	$-4,580,000	$3.50M	$0	$0	$658,000	$1.19M

Operating Expenses	$11.78M	$12.08M	$3.11M	$26.59M	$7.36M	$6.79M	$915,000	$5.54M	$15.82M	$18.23M	$22.57M	$20.69M
R&D	$6.67M	$5.96M	$5.23M	$15.56M	$5.65M	$4.04M	$8.75M	$3.88M	$9.83M	$9.64M	$14.27M	$14.65M
SG&A	$5.12M	$6.12M	$-370,000	$11.04M	$1.71M	$2.75M	$-4,567,000	$1.65M	$5.31M	$6.00M	$8.29M	$6.03M
Operating Income	$-11,784,000	$-12,079,000	$-2,313,000	$-26,594,000	$-7,358,000	$-5,995,000	$-915,000	$-2,036,000	$-15,823,000	$-18,226,000	$-21,909,000	$-19,503,000

Interest Income	$1.25M	$1.13M	$-577,000	$-96,000	$-236,000	$-77,000	$-3,706,000	$46,000	$1.92M	$2.11M	$2.27M	$2.16M
Interest Expense	$0	$0	$7.19M	$0	$227,000	$82,000	$2.67M	$1.15M	$0	$0	$0	$0
Income Before Tax	$-10,162,000	$-10,609,000	$-9,503,000	$-24,853,000	$-7,585,000	$-6,077,000	$-3,585,000	$-3,183,000	$-13,668,000	$-16,119,000	$-19,651,000	$-17,343,000
Income Tax Expense	$16,000	$10,000	$-319,000	$-74,000	$0	$0	$-76,000	$0	$62,000	$27,000	$-162,000	$0

Net Income	$-10,178,000	$-10,619,000	$-9,184,000	$-24,779,000	$-7,585,000	$-6,077,000	$-3,509,000	$-3,183,000	$-13,730,000	$-16,146,000	$-19,489,000	$-17,343,000

EBITDA	$-11,238,000	$-11,571,000	$-8,403,000	$-24,249,000	$-7,267,000	$-5,920,000	$215,000	$-1,291,000	$-15,920,000	$-18,407,000	$-21,932,000	$-19,840,000
EBIT	$-11,410,000	$-11,738,000	$-8,926,000	$-24,757,000	$-7,349,000	$-6,000,000	$121,000	$-3,229,000	$-15,588,000	$-18,233,000	$-21,923,000	$-19,505,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about IMA

News

ImageneBio stock faces a wide analyst target gap

ImageneBio stock is trading significantly below analysts' average target price, with a reported average 12-month target of USD 29.00 against a Nasdaq price of USD 4.64. Despite a Q2 EPS beat and sufficient cash to fund...

AD HOC NEWS•Sep 29, 2026 5:54 AM ET9/29/26•Neutral

Ikena Oncology stock trades without a fresh catalyst

Ikena Oncology stock (IKNA) is trading without a fresh catalyst or a substantiated same-day price snapshot, with its latest company background focusing on its oncology pipeline. The article highlights that there is no...

AD HOC NEWS•Sep 21, 2026 5:26 AM ET9/21/26•Neutral

ImageneBio (IMA) files to register 5.77M warrant shares for investor resale

ImageneBio (IMA) has filed an S-3 registration statement to allow for the resale of up to 5.77 million shares of common stock by existing selling stockholders. These shares are issuable upon the exercise of pre-funded...

Stock Titan•Aug 6, 2026 3:10 AM ET8/6/26•Neutral

ImageneBio (IMA) registers 1.37M existing shares for resale on Form S-3

ImageneBio, Inc. (IMA) has filed a Post-Effective Amendment No. 2 to convert its existing Form S-1 into a Form S-3 shelf registration...

Stock Titan•Aug 5, 2026 4:42 PM ET8/5/26•Neutral

IKNA Stock News Today | Earnings, Events & Price Alerts

Ikena Oncology (IKNA) is undergoing significant corporate changes, including a merger with Inmagene Biopharmaceuticals and a subsequent rebranding to ImageneBio...

Intellectia AI•Aug 4, 2026 12:54 PM ET8/4/26•Neutral

IMA Valuation and Fair Value

P/E: -0.8x

See GNG's fair value

IMA Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROE: -82.7%
FCF margin: -7216.6%

IMA Competitors

Company	Ticker
Sensus Healthcare Inc	SRTS
Hyperion DeFi, Inc.	HYPD
Werewolf Therapeutics Inc	HOWL
LAVA Therapeutics NV	LVTX
ETHZilla Corporation	ETHZ
Celularity Inc	CELU
Precision Optics Corporation, Inc. Common stock	POCI
Xtant Medical Holdings Inc	XTNT

Sector: Healthcare

IMA Analyst Ratings

Consensus: Hold
Analysts: 3
Strong Buy: 0
Buy: 2
Hold: 0
Sell: 1
Strong Sell: 0

IMA Bull Case vs Bear Case

Bear case

33.3% of IMA's analyst ratings are Sell or Strong Sell.

IMA Earnings: Beat Rate and Next Report

Beat rate: 5 of 8 quarters (62.5%)
Average surprise: -64.2%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.85
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 2 up, 0 down

Frequently Asked Questions About IMA

Does IMA pay dividends?

ImageneBio, Inc. (IMA) does not currently pay a regular dividend.

What is IMA's market cap?

ImageneBio, Inc. (IMA) has a market capitalization of $47.21M with a current stock price of $4.13.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In